Therapeutics

Novel, multi-asset small molecule therapeutics platform to revolutionise OCD treatment.

Transforming the treatment of gut disorders, starting with IBS, by leveraging multi-omics AI and proprietary nuclease-based technology.

Revolutionising respiratory medicine through novel aerosol technologies to improve inhaled and nasal drug delivery.